Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Allergan and MAP: Pharma Buyout With a 60% Premium
Allergan and MAP: Pharma Buyout With a 60% Premium
Allergan and MAP: Pharma Buyout With a 60% Premium
Submitted by
admin
on February 13, 2013 - 10:24am
Source:
Motley Fool
News Tags:
Allergan
MAP Pharmaceuticals
M&A
Headline:
Allergan and MAP: Pharma Buyout With a 60% Premium
Do Not Allow Advertisers to Use My Personal information
